Polar Capital Global Healthcare Trust plcLSE: PCGH

Polar Capital Global Healthcare Trust: Top Ten Equity Holdings and Exposures

· Issued by Polar Capital Global Healthcare Trust plc via RNS

Summary by 6ix AI

Polar Capital Global Healthcare Trust plc, an investment trust focused on healthcare companies, published its top ten equity holdings and its sector and geographic exposure as at September 30, 2026. Johnson & Johnson was its largest holding at 10.1%.

Key details

  • Other top holdings: Eli Lilly & Co 9.8%, UnitedHealth Group 6.1%, Roche Holding AG 5.6%, Teva Pharmaceutical Industries 4.9%, Abbott Laboratories 4.3%, Danaher 4.3%, AstraZeneca 3.8%, Agilent Technologies 3.5% and IQVIA Holdings 3.3%. The top ten together made up 55.7%.
  • Largest sector exposures: Pharmaceuticals 40.2%, Biotechnology 19.4%, Life Sciences Tools & Services 13.3%, Healthcare Equipment 13.0% and Managed Healthcare 8.5%.
  • Largest geographic exposures: United States 71.8%, United Kingdom 6.4%, Switzerland 5.6%, Israel 4.9% and Canada 3.4%.
  • Cash was listed at -8.4% in both the sector and geographic breakdowns.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/top-ten-equity-holdings-and-exposures

Polar Capital Global Health Tst PLC
05 October 2026
 

5th October 2026

Polar Capital Global Healthcare Trust plc (the “Company”)

Top Ten Equity Holdings and Sector and Geographic Exposure as at 30th September 2026.

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 30th September 2026 the top ten equity holdings and the sector and geographic breakdown were as follows:

Top 10 Holdings         

%

Johnson & Johnson

10.1%

Eli Lilly & Co

9.8%

UnitedHealth Group

6.1%

Roche Holding AG

5.6%

Teva Pharmaceutical Industries

4.9%

Abbott Laboratories

4.3%

Danaher

4.3%

AstraZeneca

3.8%

Agilent Technologies

3.5%

IQVIA Holdings

3.3%

Total

55.7%

Sector Exposure

%

Pharmaceuticals

40.2%

Biotechnology

19.4%

Life Sciences Tools & Services

13.3%

Healthcare Equipment

13.0%

Managed Healthcare

8.5%

Healthcare Services

5.9%

Healthcare Supplies

5.4%

Healthcare Distributors

1.8%

Healthcare Technology

0.8%

Healthcare Facilities

0.0%

Cash

-8.4%

Total

100.0%

Geographic Exposure

%

United States

71.8%

United Kingdom

6.4%

Switzerland

5.6%

Israel

4.9%

Canada

3.4%

China

2.2%

Italy

2.2%

India

2.0%

Germany

1.9%

Ireland

1.8%

Netherlands

1.7%

Denmark

1.3%

France

1.2%

Sweden

1.2%

Japan

0.8%

Cash

-8.4%

Total

100.0%

The monthly factsheet will usually be available on the Company’s website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Polar Capital Global Healthcare Trust plc on 6ix

Earlier from Polar Capital Global Healthcare Trust

All Polar Capital Global Healthcare Trust news releases